Roflumilast May Increase Risk of Exacerbations When Used to Treat Poorly Controlled Asthma in People with Obesity.
Sign Up to like & getrecommendations! Published in 2022 at "Annals of the American Thoracic Society"
DOI: 10.1513/annalsats.202204-368oc
Abstract: RATIONALE People with obesity often have severe, difficult to control asthma. There is a need to develop better treatments in this population. One potential treatment is roflumilast, a phosphodiesterase 4 inhibitor, as it is reported… read more here.
Keywords: poorly controlled; roflumilast; people obesity; controlled asthma ... See more keywords